# Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast Cancer

> **NCT02483767** · PHASE3 · COMPLETED · sponsor: **Peking Union Medical College Hospital** · enrollment: 98 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** goserelin
- **DRUG:** standard chemotherapy

## Key facts

- **NCT ID:** NCT02483767
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2017-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02483767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02483767, "Gonadotropin-Releasing Hormone Agonist for the Preservation of Ovarian Function During Chemotherapy in Premenopausal Breast Cancer". Retrieved via AI Analytics 2026-06-21 from https://api.ai-analytics.org/clinical/NCT02483767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*